Subjects: Drug Development and Hematologic Neoplasms -- drug therapy - Digital Collections - National Library of Medicine Search Results

Start Over Subjects Drug Development ✖ Subjects Hematologic Neoplasms -- drug therapy ✖

1. Hematologic malignancies: regulatory considerations for use of minimal residual disease in development of drug and biological products for treatment